Slip Disc Market Ready to play long term Game with Set Goal

-
The global Slip Disc market is segmented on the basis of type which comprises of thoracic herniated discs, lumbar herniated disc, and cervical herniated discs.
The Global Slip Disc Market is growing moderately and it is expected to grow at the same pace over the forecast period 2017-2018. Increasing number of patients suffering from slip disc is key factor for the market growth. Increasing number of treatments and growing awareness are also key drivers for the Slip Disc Market growth. Rising demand for advanced diagnostic medical devices and drugs, especially from emerging economies of Asia Pacific is another key factor for the market growth. Growing aging population is also one of the important drivers for the market growth. Approximately one-third of adults over the age of 20 show signs of slip disc. According to the Agency for Healthcare Research and Quality of the U.S. Department of Health & Human Services, 23% of low back pain affects patients over 65 years of age.
Major Players in Slip Disc Market
Some of the key market players: Some of the key players in this market are: Captiva Spine, Inc. (US), DePuy Synthes Companies (US), GlaxoSmithKline plc. (UK), Globus Medical, Inc. (US), NuVasive, Inc. (US), Pfizer Inc. (US), and TEVA Pharmaceutical LTD (Israel).
Slip Disc Market Regional Analysis
The global Slip Disc market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate this market, particularly North America due to increasing cases of people suffering from slip disc in the region. Availability of advanced medical facilities, and rapid adoption of new therapies are driving the market growth. Growing awareness in Latin American population regarding this disorder is major driving force.
Rising prevalence of slip disc is driving the growth for European market. As per the National Center for Biotechnology Information, the prevalence is higher among people aged 30-50 years and male to female ratio is about 2:1. The prevalence rate in Finland and Italy is about 1-3%. Some other factors such as availability of skilled medical professionals and top class medical facilities are spurring the market growth.
Rapidly developing healthcare infrastructure, adoption of new medical practices, advanced medical devices, rising healthcare expenditure, growing awareness and government support makes Asia Pacific the fastest growing region in global slip disc market. The Middle East & Africa region is expected to slower than the global average due to lack of awareness about slip disc and limited access to healthcare facilities.
Competitive landscape
Slip Disc market information, by types (thoracic herniated discs, lumbar herniated disc, and others), by diagnosis (physical examination, nerve conduction test, and others), by treatment (medications, therapy, and others) - global forecast till 2023.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Actinic Keratosis Treatment Market Share, Demand, New Opportunities and Foresight to 2024

-
Market Research Future has added a report titled “Actinic Keratosis Treatment Market Research Report- Forecast to 2024” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Report Overview: Rise in the diagnosis efficiency of various types of cancers especially those related to the skin such as actinic keratosis are growing promptly. The treatment of actinic keratosis is gaining increasing prominence due to an extensive range of factors that are contributing to the expansion of the market. Actinic keratosis is a commonly diagnosed skin disorder that can potentially progress to non-melanoma skin cancers, this particular characteristic of the disease has contributed to the demand for its treatment significantly. A typical patient example with actinic keratosis is usually observed as having fair and sun-sensitive skin. Get Premium Copy @  https://www.marketr
Read more

Wearable Medical Device Market Poised for Steady Growth in the Future 2027

-
The Global  Wearable Medical Device   Market  Research   Report provides detailed analysis of the key regional market status of the Healthcare Industry. The  Wearable Medical Device Market  is expected to reach USD 4 billion in the forecasted period. The market is expected to grow at a CAGR of 26.78%. This growth in the market can be due to various factors such as increasing focus on fitness among individuals and awareness about healthy lifestyle. Furthermore signi8ficant growth in the home healthcare is expected to push up the demand for this segment. Top key players in the  wearable Medical Device market  are:  Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics. Get Sample copy at  https://www.marketresearchfuture.com/sample_request/899  . Segments The  Wearable Medical Device Market  can be
Read more

Peripheral Artery Disease Market Will Watch a Sensational Development by 2023: Industry Assertions by MRFR

-
MRFR is the Leading Brand in The Research Company who Recently Published Peripheral Artery Disease Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023. Get Sample Copy @   https://www.marketresearchfuture.com/sample_request/1540 Industry Leading Players: Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V, Abbott, Medtronic, B. Braun Melsungen AG, TERUMO CORPORATION, Becton, Dickinson and Company (BD), Sanofi S.A., Johnson & Johnson Services, Inc., AstraZeneca Plc., Angioscore, Inc., Bristol-Myers Squibb Company, Betagenon AB, Proteon Therapeutics, Inc., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals, Symic Bio, Inc., CardioVascular BioTherapeutics, Inc., AnGes, Inc., TheraVasc Inc., Smith & Nephew plc, Stryker Corporation, Cook Medical, Cordis, Aspen Surgical Products, Inc., Alcon Laboratories, Inc., Zimmer Biomet Holdings, Inc., and others are some of
Read more